Market Cap 8.05B
Revenue (ttm) 2.09B
Net Income (ttm) -304.90M
EPS (ttm) N/A
PE Ratio 27.20
Forward PE 28.10
Profit Margin -14.56%
Debt to Equity Ratio 0.57
Volume 646,700
Avg Vol 686,174
Day's Range N/A - N/A
Shares Out 54.33M
Stochastic %K 72%
Beta 1.23
Analysts Strong Sell
Price Target $187.57

Company Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of oxygen, carboxyhemog...

Industry: Medical Devices
Sector: Healthcare
Phone: 949 297 7000
Fax: 949 297 7001
Address:
52 Discovery, Irvine, United States
JarvisFlow
JarvisFlow Sep. 11 at 1:12 PM
BTIG has adjusted their stance on Masimo ( $MASI ), setting the rating to Buy with a target price of 198.
0 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 11 at 12:04 PM
$MASI Excellent article that nails exactly where MASI stands right now. So if you want to update your MASI knowledge or get acquainted with MASI, this is a must read. https://beyondspx.com/quote/MASI/analysis/precision-profit-masimo-s-strategic-recalibration-for-healthcare-dominance-nasdaq-masi
0 · Reply
11thestate
11thestate Sep. 8 at 3:20 PM
Took a hit on $MASI? You’re not alone — and there’s a way forward. Find out how to recover: https://11th.com/cases/masimo-investor-lawsuit?utm_source=stocktwits&utm_medium=referral&utm_campaign=stlm&utm_content=09082025_1 #MASI
0 · Reply
11thestate
11thestate Aug. 28 at 12:12 PM
$MASI has agreed to settle $33,750,000 with investors to resolve claims that it misled the market about its ability to sustain growth following its $1 billion acquisition of Sound United. Who’s eligible? Anyone who purchased $MASI shares between May 4, 2022, and August 8, 2023. Do I need to sell my shares to qualify? No — you are eligible whether you sold your shares or still hold them. How much is the payout? The payout per share is $1.30 — but if only ~25% of eligible investors file, the effective payout could increase to $5.20. Can I still file? Yes — claims are currently being accepted. When do payouts happen? Typically within 8–12 months after court approval of the settlement. To file your claim: https://11th.com/cases/masimo-investor-lawsuit?utm_source=stocktwits&utm_medium=referral&utm_campaign=faq&utm_content=08282025_1
0 · Reply
Estimize
Estimize Aug. 27 at 1:00 PM
Wall St is expecting 1.20 EPS for $MASI Q3 [Reporting 11/11 AMC] http://www.estimize.com/intro/masi?chart=historical&metric_name=eps&utm_co
0 · Reply
DonCorleone77
DonCorleone77 Aug. 21 at 10:17 AM
$MASI $AAPL From Bloomberg Law: "Masimo Sues Customs Over Apple Watch’s Restored Oxygen Tool" https://news.bloomberglaw.com/daily-labor-report/masimo-sues-us-customs-over-apple-restoring-watchs-oxygen-tool
0 · Reply
smartkarma
smartkarma Aug. 21 at 6:06 AM
$MASI | Masimo Corporation Unveils Next-Gen Root Monitor; Can Its Innovations Help Grap A Larger Pie Of The Market? "Masimo Corporation’s second quarter of 2025 presents a mixed yet interesting picture for potential investors, focusing predominantly on the..." - Baptista Research (Baptista Research) Read more: https://www.smartkarma.com/insights/masimo-corporation-unveils-next-gen-root-monitor-can-its-innovations-help-grap-a-larger-pie-of-the-market
0 · Reply
StocktwitsNews
StocktwitsNews Aug. 21 at 3:01 AM
Apple’s Watch War Heats Up: Masimo Takes Customs To Court Over Blood-Oxygen Feature $MASI $AAPL https://stocktwits.com/news/equity/markets/apple-s-watch-war-heats-up-masimo-takes-customs-to-court-over-blood-oxygen-feature/chsSKuFRdL7
0 · Reply
ZacksResearch
ZacksResearch Aug. 20 at 6:13 PM
$MASI shares lost 4.6% following FDA clearance for expanded O3 Regional Oximetry indications — a buying opportunity? 🤔 FDA nod for expanded O3 Regional Oximetry indications could drive growth in high-margin brain monitoring, yet shares are down 11.2% year-to-date, underperforming the industry’s 7.6% decline. Discover what's next for Masimo 👉 https://www.zacks.com/stock/news/2740478/masimo-shares-dip-despite-fda-clears-expanded-use-of-o3-monitoring?cid=sm-stocktwits-2-2740478-body-8701&ADID=SYND_STOCKTWITS_TWEET_2_2740478_BODY_8701
0 · Reply
ZacksResearch
ZacksResearch Aug. 20 at 5:13 PM
$MASI dips on FDA win? 🤔 The company just got clearance to expand O3 monitoring with delta hemoglobin parameters across all patient groups — yet shares are trading lower. See the full bull/bear setup here 👉 https://www.zacks.com/stock/news/2740478/masimo-shares-dip-despite-fda-clears-expanded-use-of-o3-monitoring?cid=sm-stocktwits-2-2740478-teaser-8700&ADID=SYND_STOCKTWITS_TWEET_2_2740478_TEASER_8700
0 · Reply
Latest News on MASI
Masimo to Present in the Wells Fargo Healthcare Conference

Aug 28, 2025, 9:00 AM EDT - 14 days ago

Masimo to Present in the Wells Fargo Healthcare Conference


Masimo sues US Customs over approval of Apple Watch imports

Aug 20, 2025, 6:52 PM EDT - 22 days ago

Masimo sues US Customs over approval of Apple Watch imports

AAPL


Masimo Corporation (MASI) Q2 2025 Earnings Call Transcript

Aug 5, 2025, 11:03 PM EDT - 5 weeks ago

Masimo Corporation (MASI) Q2 2025 Earnings Call Transcript


Masimo Reports Second Quarter 2025 Results

Aug 5, 2025, 4:05 PM EDT - 5 weeks ago

Masimo Reports Second Quarter 2025 Results


Masimo to Present in the Jefferies Global Healthcare Conference

May 27, 2025, 9:00 AM EDT - 3 months ago

Masimo to Present in the Jefferies Global Healthcare Conference


Masimo Corporation (MASI) Q1 2025 Earnings Call Transcript

May 6, 2025, 10:15 PM EDT - 4 months ago

Masimo Corporation (MASI) Q1 2025 Earnings Call Transcript


Masimo Reports First Quarter 2025 Results

May 6, 2025, 4:10 PM EDT - 4 months ago

Masimo Reports First Quarter 2025 Results


Masimo to Sell Consumer Audio Business to HARMAN International

May 6, 2025, 4:10 PM EDT - 4 months ago

Masimo to Sell Consumer Audio Business to HARMAN International


Masimo to Sell Audio Business to Harman After Investor Outrage

May 6, 2025, 4:00 PM EDT - 4 months ago

Masimo to Sell Audio Business to Harman After Investor Outrage


Masimo Corporation (MASI) Q4 2024 Earnings Call Transcript

Feb 25, 2025, 6:02 PM EST - 7 months ago

Masimo Corporation (MASI) Q4 2024 Earnings Call Transcript


Masimo Taps Katie Szyman as Permanent CEO

Jan 21, 2025, 5:22 PM EST - 8 months ago

Masimo Taps Katie Szyman as Permanent CEO


Masimo names Becton Dickinson's Katie Szyman CEO

Jan 21, 2025, 4:56 PM EST - 8 months ago

Masimo names Becton Dickinson's Katie Szyman CEO


Masimo Announces Leadership Transition

Jan 21, 2025, 4:00 PM EST - 8 months ago

Masimo Announces Leadership Transition


Masimo to Present in the Jefferies London Healthcare Conference

Nov 14, 2024, 9:00 AM EST - 10 months ago

Masimo to Present in the Jefferies London Healthcare Conference


Masimo to Present in Stifel 2024 Healthcare Conference

Nov 13, 2024, 9:00 AM EST - 10 months ago

Masimo to Present in Stifel 2024 Healthcare Conference


Masimo Corporation (MASI) Q3 2024 Earnings Call Transcript

Nov 5, 2024, 7:57 PM EST - 11 months ago

Masimo Corporation (MASI) Q3 2024 Earnings Call Transcript


Masimo Reports Third Quarter 2024 Financial Results

Nov 5, 2024, 4:05 PM EST - 11 months ago

Masimo Reports Third Quarter 2024 Financial Results


Masimo Terminates Founder Kiani as CEO

Oct 29, 2024, 5:57 PM EDT - 11 months ago

Masimo Terminates Founder Kiani as CEO


Apple wins $250 from Masimo in watch patent trial

Oct 26, 2024, 3:53 PM EDT - 11 months ago

Apple wins $250 from Masimo in watch patent trial

AAPL


Masimo smartwatches infringe Apple design patents, US jury says

Oct 25, 2024, 6:16 PM EDT - 11 months ago

Masimo smartwatches infringe Apple design patents, US jury says

AAPL


Masimo's Joe Kiani resigns as CEO after board ouster

Sep 25, 2024, 9:17 AM EDT - 1 year ago

Masimo's Joe Kiani resigns as CEO after board ouster


Masimo Provides Leadership and Business Updates

Sep 25, 2024, 9:00 AM EDT - 1 year ago

Masimo Provides Leadership and Business Updates


Politan Comments on Results of Masimo's 2024 Annual Meeting

Sep 19, 2024, 5:39 PM EDT - 1 year ago

Politan Comments on Results of Masimo's 2024 Annual Meeting


JarvisFlow
JarvisFlow Sep. 11 at 1:12 PM
BTIG has adjusted their stance on Masimo ( $MASI ), setting the rating to Buy with a target price of 198.
0 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 11 at 12:04 PM
$MASI Excellent article that nails exactly where MASI stands right now. So if you want to update your MASI knowledge or get acquainted with MASI, this is a must read. https://beyondspx.com/quote/MASI/analysis/precision-profit-masimo-s-strategic-recalibration-for-healthcare-dominance-nasdaq-masi
0 · Reply
11thestate
11thestate Sep. 8 at 3:20 PM
Took a hit on $MASI? You’re not alone — and there’s a way forward. Find out how to recover: https://11th.com/cases/masimo-investor-lawsuit?utm_source=stocktwits&utm_medium=referral&utm_campaign=stlm&utm_content=09082025_1 #MASI
0 · Reply
11thestate
11thestate Aug. 28 at 12:12 PM
$MASI has agreed to settle $33,750,000 with investors to resolve claims that it misled the market about its ability to sustain growth following its $1 billion acquisition of Sound United. Who’s eligible? Anyone who purchased $MASI shares between May 4, 2022, and August 8, 2023. Do I need to sell my shares to qualify? No — you are eligible whether you sold your shares or still hold them. How much is the payout? The payout per share is $1.30 — but if only ~25% of eligible investors file, the effective payout could increase to $5.20. Can I still file? Yes — claims are currently being accepted. When do payouts happen? Typically within 8–12 months after court approval of the settlement. To file your claim: https://11th.com/cases/masimo-investor-lawsuit?utm_source=stocktwits&utm_medium=referral&utm_campaign=faq&utm_content=08282025_1
0 · Reply
Estimize
Estimize Aug. 27 at 1:00 PM
Wall St is expecting 1.20 EPS for $MASI Q3 [Reporting 11/11 AMC] http://www.estimize.com/intro/masi?chart=historical&metric_name=eps&utm_co
0 · Reply
DonCorleone77
DonCorleone77 Aug. 21 at 10:17 AM
$MASI $AAPL From Bloomberg Law: "Masimo Sues Customs Over Apple Watch’s Restored Oxygen Tool" https://news.bloomberglaw.com/daily-labor-report/masimo-sues-us-customs-over-apple-restoring-watchs-oxygen-tool
0 · Reply
smartkarma
smartkarma Aug. 21 at 6:06 AM
$MASI | Masimo Corporation Unveils Next-Gen Root Monitor; Can Its Innovations Help Grap A Larger Pie Of The Market? "Masimo Corporation’s second quarter of 2025 presents a mixed yet interesting picture for potential investors, focusing predominantly on the..." - Baptista Research (Baptista Research) Read more: https://www.smartkarma.com/insights/masimo-corporation-unveils-next-gen-root-monitor-can-its-innovations-help-grap-a-larger-pie-of-the-market
0 · Reply
StocktwitsNews
StocktwitsNews Aug. 21 at 3:01 AM
Apple’s Watch War Heats Up: Masimo Takes Customs To Court Over Blood-Oxygen Feature $MASI $AAPL https://stocktwits.com/news/equity/markets/apple-s-watch-war-heats-up-masimo-takes-customs-to-court-over-blood-oxygen-feature/chsSKuFRdL7
0 · Reply
ZacksResearch
ZacksResearch Aug. 20 at 6:13 PM
$MASI shares lost 4.6% following FDA clearance for expanded O3 Regional Oximetry indications — a buying opportunity? 🤔 FDA nod for expanded O3 Regional Oximetry indications could drive growth in high-margin brain monitoring, yet shares are down 11.2% year-to-date, underperforming the industry’s 7.6% decline. Discover what's next for Masimo 👉 https://www.zacks.com/stock/news/2740478/masimo-shares-dip-despite-fda-clears-expanded-use-of-o3-monitoring?cid=sm-stocktwits-2-2740478-body-8701&ADID=SYND_STOCKTWITS_TWEET_2_2740478_BODY_8701
0 · Reply
ZacksResearch
ZacksResearch Aug. 20 at 5:13 PM
$MASI dips on FDA win? 🤔 The company just got clearance to expand O3 monitoring with delta hemoglobin parameters across all patient groups — yet shares are trading lower. See the full bull/bear setup here 👉 https://www.zacks.com/stock/news/2740478/masimo-shares-dip-despite-fda-clears-expanded-use-of-o3-monitoring?cid=sm-stocktwits-2-2740478-teaser-8700&ADID=SYND_STOCKTWITS_TWEET_2_2740478_TEASER_8700
0 · Reply
11thestate
11thestate Aug. 18 at 8:51 PM
Took a hit on $MASI? You’re not alone — and there’s a way forward. Find out how to recover: https://11th.com/cases/masimo-investor-lawsuit?utm_source=stocktwits&utm_medium=referral&utm_campaign=stlm&utm_content=08182025_1 #MASI
0 · Reply
lipmaz
lipmaz Aug. 17 at 12:05 AM
$MASI or $IRTC you can only choose one?
0 · Reply
theflynews
theflynews Aug. 14 at 3:19 PM
Video: Why Masimo Is Sliding Today - $MASI - https://thefly.com/permalinks/entry.php/MASIid4183702?1755184131C38
0 · Reply
healthcareguru
healthcareguru Aug. 11 at 1:54 PM
Dramatically oversold and ready for tactical longs: $MASI $ICUI $LLY $HAE 👍
0 · Reply
healthcareguru
healthcareguru Aug. 8 at 5:34 PM
All of these are massively and unjustifiably oversold despite strong or decent fundamentals…BUY THE F*CKING DIP on all of these: $LLY $HAE $EVH $ICUI $MASI 💪👍
1 · Reply
ZacksResearch
ZacksResearch Aug. 6 at 6:09 PM
$MASI posts strong Q2 earnings beat — despite shares dipping 2.7% after hours. 🤔 📈 Adjusted EPS surged 46.2% YoY, beating the Zacks Consensus Estimate by 8.1% 💰 Revenue grew 7.9% YoY on a reported basis, driven by consumable sales, despite lower capital sales See the full breakdown here 👉 https://www.zacks.com/stock/news/2674068/masi-stock-slips-despite-q2-earnings-and-revenue-beat-margins-expand?cid=sm-stocktwits-2-2674068-body-6468&ADID=SYND_STOCKTWITS_TWEET_2_2674068_BODY_6468
0 · Reply
garygb
garygb Aug. 6 at 5:51 PM
$MASI Sold off for no reason. I'm buying in
0 · Reply
healthcareguru
healthcareguru Aug. 6 at 5:13 PM
$MASI no reason for this to be down so much on a nice EPS guide boost; bouncing nicely…looks like it wants a >$150 close. 👍
0 · Reply
ZacksResearch
ZacksResearch Aug. 6 at 4:56 PM
$MASI crushed Q2 — so why is the stock slipping? 🤔 Earnings and revenue both topped estimates, margins expanded, and the 2025 outlook was raised. Full breakdown here 👉 https://www.zacks.com/stock/news/2674068/masi-stock-slips-despite-q2-earnings-and-revenue-beat-margins-expand?cid=sm-stocktwits-2-2674068-teaser-6406&ADID=SYND_STOCKTWITS_TWEET_2_2674068_TEASER_6406
0 · Reply
JarvisFlow
JarvisFlow Aug. 6 at 4:06 PM
Piper Sandler updates rating for Masimo ( $MASI ) to Overweight, target set at 200 → 210.
0 · Reply
nanidog
nanidog Aug. 6 at 2:51 PM
$MASI earning out
0 · Reply
1986iamwallstreet
1986iamwallstreet Aug. 5 at 8:46 PM
$MASI bleeding 🩸
0 · Reply